Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Osteosarcoma 1Neurofibroma, Plexiform 1Neurofibroma 1Neuroblastoma 1Melanoma 1Hepatoblastoma 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 8Temozolomide 6Topotecan 5Melphalan 5Granulocyte Colony-Stimulating Factor 5X-Rays 4Phantoms, Imaging 4Irinotecan 4palbociclib 3fludarabine 3Vincristine 3Specimen Handling 3Sirolimus 3Magnetic Resonance Spectroscopy 3Busulfan 3Bone Marrow Transplantation 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2ivosidenib 2irinotecan sucrosofate 2cabozantinib 2abemaciclib 2Zoledronic Acid 2Vemurafenib 2Nuclear Medicine Department, Hospital 2Nivolumab 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Cryotherapy × CNS × Clear all
NCT05302921 2025-01-01

Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors

Children's National Research Institute

Phase 2 Completed
5 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Melanoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡